The sixth instalment in the ‘Jurassic’ saga features Scarlett Johansson, Mahershala Ali and Jonathan Bailey in key roles ...

Two Biotechs Poised For Big Moves On Monday (Sana Biotechnology | Lineage Cell Therapeutics) Catalyst: Invited six-month ...

Eolo Pharma, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, today announced the publication of its first-in-human study in Nature Metabolism, ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Sana Biotechnology Inc.

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Sana Biotechnology Inc. (NASDAQ:SANA) stands ...

On Friday, Jefferies initiated coverage on Sana Biotechnology stock (NASDAQ: SANA) with a Buy rating and set a price target of $7.00. The stock, currently trading at $2.66, has shown strong ...

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA ...

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands ...

Sana Biotechnology Inc (NASDAQ:SANA) is a biotech company that makes engineered cells as medicines. It is making therapies for conditions including type 1 diabetes, autoimmune diseases, and cancer.

Sana Biotechnology (SANA), a clinical-stage biotech company specializing in gene and cell therapies, has recently experienced significant moves in its stock performance, attracting investor ...

Sana Biotech extends rally as Morgan Stanley cites platform's potential Jan. 08, 2025 2:40 PM ET Sana Biotechnology, Inc. (SANA) Stock By: Dulan Lokuwithana, SA News Editor Play (<1min) ModernLife ...

On Wednesday, Sana Biotechnology shares received an upgrade from TD Cowen analysts, shifting from a Hold to a Buy rating. The upgrade was prompted by Sana's announcement of positive interim study ...